Verastem, Inc.
VSTM
$8.57
-$0.67-7.25%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
10/11/2025
-
Tickeron - Stocks
10/10/2025
-
TipRanks Financial Blog
10/9/2025
-
MarketBeat
10/8/2025
-
SeekingAlpha
10/7/2025
-
MarketBeat
10/7/2025
-
GuruFocus
10/7/2025
-
Business Wire
10/7/2025
-
Tickeron - Technical Analysis
10/6/2025
-
MarketBeat
10/4/2025
-
Tickeron - Stocks
10/4/2025
-
MarketBeat
9/25/2025
-
Simply Wall St
9/24/2025
-
Ticker Report
9/23/2025
-
Zolmax
9/22/2025
-
Stock Options Channel
9/21/2025
-
MarketBeat
9/19/2025
-
GuruFocus
9/18/2025
-
MarketBeat
9/18/2025
-
Ticker Report
9/18/2025
-
MarketBeat
9/17/2025
-
Tickeron - Stocks
9/17/2025
-
Tickeron - Stocks
9/16/2025
-
Tickeron - Stocks
9/15/2025
-
MarketBeat
9/13/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 7, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
781 292 4200
Address
117 Kendrick Street
Needham, MA 02494
Needham, MA 02494
Country
Year Founded
Business Description
Sector
Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are...
more